CGTX

Cognition Therapeutics Inc
1.9001
-0.0799 (-4.04%)
Company Name Stock Ticker Symbol Market Type
Cognition Therapeutics Inc CGTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0799 -4.04% 1.9001 10:40:02
Open Price Low Price High Price Close Price Prev Close
1.98 1.87 1.98 1.98
more quote information »

Recent News

Date Time Source Heading
2/07/20239:17IHNWFeaturedAmerican Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7,
2/07/20237:00IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone
1/04/202306:05EDGARNotice of Effectiveness (effect)
12/23/202216:25EDGARCurrent Report Filing (8-k)
12/23/202216:17EDGARSecurities Registration Statement (simplified Form) (s-3)
12/22/202208:00GLOBECognition Therapeutics Announces New “Conversations” Podcast..
12/21/202216:05GLOBECognition Therapeutics Announces Participation in Sachs 6th..
12/15/202208:00GLOBEFirst Participant Dosed in Europe as Cognition Therapeutics..
12/05/202217:27EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/01/202207:30GLOBECognition Therapeutics Presents Scientific Rationale,..
11/28/202208:00GLOBECognition Therapeutics Highlights Phase 2 SHIMMER Study of..
11/21/202208:00GLOBECognition Therapeutics Launches Neuroscience Thought Leader..
11/18/202207:22EDGARStatement of Ownership (sc 13g)
11/16/202217:19EDGARCurrent Report Filing (8-k)
11/16/202208:31EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202208:31EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202207:01EDGARStatement of Changes in Beneficial Ownership (4)
11/15/202212:55GLOBECognition Therapeutics Announces Closing of Public Offering
11/14/202208:18EDGARQuarterly Report (10-q)
11/14/202208:01EDGARCurrent Report Filing (8-k)
11/14/202208:00GLOBECognition Therapeutics Reports Third Quarter 2022 Financial..
11/14/202206:09EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
11/10/202208:00GLOBECognition Therapeutics Announces Pricing of Public Offering
11/10/202206:05EDGARNotice of Effectiveness (effect)
11/07/202217:12EDGARSecurities Registration Statement (s-1)
10/12/202208:00GLOBECognition Therapeutics is Recruiting for Lewy Body Dementia..
10/11/202208:00GLOBECognition Therapeutics Appoints CNS Drug Development Expert..
9/29/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
9/29/202207:30GLOBECognition Therapeutics to Participate in the 2022 Cantor..
9/27/202207:32GLOBECognition Therapeutics Awarded $2.14 Million in Supplemental..
9/06/202207:32GLOBECognition Therapeutics Announces Participation in September..
8/15/202216:08EDGARInitial Statement of Beneficial Ownership (3)
8/09/202207:16EDGARCurrent Report Filing (8-k)
8/09/202207:00GLOBECognition Therapeutics Reports Second Quarter 2022 Financial..
8/05/202203:35TRMNCognition Therapeutics (CGTX) Receives a Buy from B.Riley..
8/04/202216:02GLOBECognition Therapeutics Presents New Proteomic Data on Effect..
8/03/202216:05GLOBECognition Therapeutics to Report Second Quarter 2022..
7/19/202208:00GLOBECognition Therapeutics Presenting New Analyses from Ongoing..
6/30/202212:07EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202216:08EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202216:08EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202216:08EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202216:06EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
6/23/202207:30GLOBECognition Therapeutics Doses First Patient with Dementia..
6/16/202207:09EDGARCurrent Report Filing (8-k)
6/13/202217:08EDGARCurrent Report Filing (8-k)
6/13/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202207:30GLOBECognition Therapeutics Announces Presentation at the..
6/02/202216:01GLOBECognition Therapeutics to Host Virtual KOL Symposium on Dry..